News

India-based pharmaceutical company Dr Reddy’s Laboratories has realigned its global generics finished dosages strategy to focus on certain key geographies and would gradually exit some of the very

Nordhoff, who has led Gen-Probe since 1994, will become non-executive chairman upon his re-election to the board by stockholders at the company’s 2009 annual meeting. “I’m delighted to

Neoprobe, a biomedical company, has announced that a multicenter Phase III study of Lymphoseek has reached the accrual of 203 lymph nodes, the study’s primary accrual objective. The

He will also assist in the selection of new product candidates and licensing opportunities for Fujirebio Diagnostics products. He has held various positions at Abbott and Meridian Bioscience,

Warner Chilcott, a specialty pharmaceutical company, has announced that one of its subsidiaries and Mayne Pharma International have filed a second lawsuit against Impax Laboratories, in the District

The company has also announced that it will concentrate its cash resources on the clinical and commercial development of its late-stage oncology candidate, picoplatin. The company continues to

Lifeline Biotechnologies has agreed to assume a convertible debt from Solos, which will result in less dilution for its shareholders. In addition, the sale of the Ovascope and

Under the agreement, Mayo Clinic will become a participant in The Global Prevention Network, a select group of pre-eminent healthcare institutions with recognized research, preventive services and executive

The lawsuit was filed in response to an abbreviated new drug application (ANDA) filed by Mylan seeking the FDA approval to market and sell generic versions of Shire’s